Plain-English translation of NCT05085704 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how the brain uses glucose (sugar) for energy, especially in people with Glut1 deficiency — a rare genetic disorder that affects how glucose gets to the brain. This study uses advanced MRI brain scans and a special type of glucose labeled with a tracer to track how the brain processes and uses glucose.
Glut1 deficiency is a rare condition where the brain cannot properly access glucose, which can cause seizures and other problems. This research aims to better understand exactly how glucose metabolism goes wrong in affected people, which could lead to better treatments in the future.
You likely qualify if…
You likely don't qualify if…
You will receive a special glucose tracer by mouth, then lie inside an MRI machine for a brain scan. The scan will measure how your brain processes the glucose. You may have scans on either a 3 Tesla or 7 Tesla MRI machine. The visit will involve screening tests (including a pregnancy test if applicable) and the imaging session itself.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
Weill Medical College of Cornell University
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Enrollment target
~20 participants
Started
May 2022
Primary completion
June 2029
Age range
16 Years – 80 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Juan M Pascual, M.D.
Weill Medical College of Cornell University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.